Results 91 to 100 of about 2,325 (152)

AS1411 Aptamer-Conjugated Liposomal siRNA Targeting MTA2 Suppresses PI3K/AKT Signaling in Pancreatic Cancer Cells. [PDF]

Int J Mol Sci
Kwak M, Hua TC, Jin H, Lee J, Kim DE.
europepmc   +1 more source

Preparation of AS1411 Aptamer Modified Mn-MoS₂ QDs for Targeted MR Imaging and Fluorescence Labelling of Renal Cell Carcinoma. [PDF]

Int J Nanomedicine, 2019
Zheng S, Zhang M, Bai H, He M, Dong L, Cai L, Zhao M, Wang Q, Xu K, Li J.   +9 more
europepmc   +1 more source

Simultaneous targeted delivery of doxorubicin and KRAS suppression by a hybrid molecule containing miR-143 and AS1411 aptamer. [PDF]

Sci Rep
Laowichuwakonnukul K, Soontornworajit B, Arunpanichlert J, Rotkrua P.   +3 more
europepmc   +1 more source

Selective alkylation and bioactivity of phosphorothioated nucleolin aptamer AS1411

Journal Of Chinese Pharmaceutical Sciences, 2017
openaire   +1 more source

AS1411 aptamer-modified theranostic liposomes co-encapsulating manganese oxide nano-contrast agent and paclitaxel for MRI and therapy of cancer. [PDF]

RSC Adv, 2019
Li J, Li Q, He M, Ding F, Cai L, Zhao M, Dong L, Wang Q, Xu K.   +8 more
europepmc   +1 more source

Aptamers in cancer therapy: Why has clinical translation lagged behind preclinical promise? [PDF]

Biomed Pharmacother
Tran TT, Tran VL, Fishel ML, Nguyen BT, Zhang J, Condello S, Zhong X, Schmidt M.   +7 more
europepmc   +1 more source

Synthetic aptamer mechanoreceptors enable cell-specific force sensing and temporal control via DNA circuits. [PDF]

Nat Commun
Xu T, Sethi S, Drees C, Walther A.
europepmc   +1 more source

Therapeutic Potential of Peptides in Cancer Treatment: Focus on Peptide and Aptamer-Decorated Exosomes. [PDF]

Cancers (Basel)
Gangadaran P, Kumar AS, Kumaran K, Prakash K, Dhayalan S, Rajendran RL, Loganathbabu VKT, Balaji J, Baskaran R, Arun R, Karthikeyan V, Biswas S, Hong CM, ArulJothi KN, Ahn BC.   +14 more
europepmc   +1 more source

Research advances in aptamers in the diagnosis and treatment of breast cancer (Review). [PDF]

Int J Oncol
Chu L, Xiao Y, Li X, Cui J, Ma L, Shao B, Cui H.   +6 more
europepmc   +1 more source

Fulfilling multiple roles in PROTAC design: The emerging potential of oligonucleotides. [PDF]

Eur J Med Chem
Rodrigues DA, Pires GS, Roy U, Conway E, de Sena Murteira Pinheiro P.   +4 more
europepmc   +1 more source